Decoding the transcriptome from bulk RNA of infection-naïve versus imprinted patients with SARS-CoV-2 Omicron B.1.1.529

ABSTRACT Total RNA-seq allows for the comprehensive detection of differentially expressed genes (DEGs), providing insight into immune responses during infection. In this study, we addressed the question of whether total RNA-seq can detect differences in gene expression and, therefore, immune respons...

Full description

Saved in:
Bibliographic Details
Main Authors: Sissy Therese Sonnleitner, Samira Walder, Eva Hinterbichler, Ludwig Knabl, Roswitha Poernbacher, Gernot Walder
Format: Article
Language:English
Published: American Society for Microbiology 2025-08-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.02914-24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850039265017200640
author Sissy Therese Sonnleitner
Samira Walder
Eva Hinterbichler
Ludwig Knabl
Roswitha Poernbacher
Gernot Walder
author_facet Sissy Therese Sonnleitner
Samira Walder
Eva Hinterbichler
Ludwig Knabl
Roswitha Poernbacher
Gernot Walder
author_sort Sissy Therese Sonnleitner
collection DOAJ
description ABSTRACT Total RNA-seq allows for the comprehensive detection of differentially expressed genes (DEGs), providing insight into immune responses during infection. In this study, we addressed the question of whether total RNA-seq can detect differences in gene expression and, therefore, immune responses between infection-naïve and imprinted patients. By sequencing all DEGs in the acute phase of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron B.1.1.529 infection, we examined the biological processes that characterize patients with different immune statuses. We differentiated between infection-naïve individuals (Group A), individuals imprinted by prior SARS-CoV-2 infection (Group B), and individuals first imprinted by vaccination (Group C). Infection status was confirmed by SARS-CoV-2-specific PCR; viral strain identification was performed via melting curve analysis; and immune status was assessed by chemiluminescent immunoassay. Our findings revealed significant transcriptomic differences between the study groups. Infection-naïve individuals exhibited the highest number of differentially expressed genes (1,526 DEGs), compared to 27 in previously infected individuals and only seven in vaccinated individuals. A key aspect of this difference was the expression of interferon-stimulated genes, which showed a progressive decline from infection-naïve to previously infected to vaccinated individuals. Notably, Group C displayed almost no upregulated genes but instead exhibited significant downregulation in pathways related to DNA metabolism. A key strength of our study is the inclusion of infection-naïve individuals at a time when most of the population had already been exposed to SARS-CoV-2. This rare opportunity allowed us to characterize the primary immune response to Omicron B.1.1.529 in infection-naïve individuals and compare it to immune responses shaped by prior infection or vaccination. The clear differences in gene expression between these groups highlight how prior exposure influences immune activation during acute infection.IMPORTANCEUnderstanding how prior immune imprinting through infection or vaccination influences the transcriptomic response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial for optimizing vaccine strategies and predicting immune outcomes in future pandemics. A unique strength of our study is the inclusion of infection-naïve individuals at a time when most of the population had already been exposed to SARS-CoV-2. This rare opportunity allowed us to characterize the primary immune response to Omicron B.1.1.529 and compare it to responses shaped by prior infection or vaccination, providing valuable insights into how immune imprinting influences transcriptional activation during acute infection.
format Article
id doaj-art-9c516bf8eab9469bbded0206f0fd802b
institution DOAJ
issn 2165-0497
language English
publishDate 2025-08-01
publisher American Society for Microbiology
record_format Article
series Microbiology Spectrum
spelling doaj-art-9c516bf8eab9469bbded0206f0fd802b2025-08-20T02:56:24ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972025-08-0113810.1128/spectrum.02914-24Decoding the transcriptome from bulk RNA of infection-naïve versus imprinted patients with SARS-CoV-2 Omicron B.1.1.529Sissy Therese Sonnleitner0Samira Walder1Eva Hinterbichler2Ludwig Knabl3Roswitha Poernbacher4Gernot Walder5Department of Virology, Medical Laboratory, Dr. Gernot Walder GmbH, Ausservillgraten, AustriaDepartment of Virology, Medical Laboratory, Dr. Gernot Walder GmbH, Ausservillgraten, AustriaDepartment of Virology, Medical Laboratory, Dr. Gernot Walder GmbH, Ausservillgraten, AustriaInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, AustriaDepartment of Virology, Medical Laboratory, Dr. Gernot Walder GmbH, Ausservillgraten, AustriaDepartment of Virology, Medical Laboratory, Dr. Gernot Walder GmbH, Ausservillgraten, AustriaABSTRACT Total RNA-seq allows for the comprehensive detection of differentially expressed genes (DEGs), providing insight into immune responses during infection. In this study, we addressed the question of whether total RNA-seq can detect differences in gene expression and, therefore, immune responses between infection-naïve and imprinted patients. By sequencing all DEGs in the acute phase of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron B.1.1.529 infection, we examined the biological processes that characterize patients with different immune statuses. We differentiated between infection-naïve individuals (Group A), individuals imprinted by prior SARS-CoV-2 infection (Group B), and individuals first imprinted by vaccination (Group C). Infection status was confirmed by SARS-CoV-2-specific PCR; viral strain identification was performed via melting curve analysis; and immune status was assessed by chemiluminescent immunoassay. Our findings revealed significant transcriptomic differences between the study groups. Infection-naïve individuals exhibited the highest number of differentially expressed genes (1,526 DEGs), compared to 27 in previously infected individuals and only seven in vaccinated individuals. A key aspect of this difference was the expression of interferon-stimulated genes, which showed a progressive decline from infection-naïve to previously infected to vaccinated individuals. Notably, Group C displayed almost no upregulated genes but instead exhibited significant downregulation in pathways related to DNA metabolism. A key strength of our study is the inclusion of infection-naïve individuals at a time when most of the population had already been exposed to SARS-CoV-2. This rare opportunity allowed us to characterize the primary immune response to Omicron B.1.1.529 in infection-naïve individuals and compare it to immune responses shaped by prior infection or vaccination. The clear differences in gene expression between these groups highlight how prior exposure influences immune activation during acute infection.IMPORTANCEUnderstanding how prior immune imprinting through infection or vaccination influences the transcriptomic response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial for optimizing vaccine strategies and predicting immune outcomes in future pandemics. A unique strength of our study is the inclusion of infection-naïve individuals at a time when most of the population had already been exposed to SARS-CoV-2. This rare opportunity allowed us to characterize the primary immune response to Omicron B.1.1.529 and compare it to responses shaped by prior infection or vaccination, providing valuable insights into how immune imprinting influences transcriptional activation during acute infection.https://journals.asm.org/doi/10.1128/spectrum.02914-24transcriptome analysistotal RNA-seqimprinted immune responseinfection-naïve immune responseSARS-CoV-2 Omicron B.1.1.529gene expression
spellingShingle Sissy Therese Sonnleitner
Samira Walder
Eva Hinterbichler
Ludwig Knabl
Roswitha Poernbacher
Gernot Walder
Decoding the transcriptome from bulk RNA of infection-naïve versus imprinted patients with SARS-CoV-2 Omicron B.1.1.529
Microbiology Spectrum
transcriptome analysis
total RNA-seq
imprinted immune response
infection-naïve immune response
SARS-CoV-2 Omicron B.1.1.529
gene expression
title Decoding the transcriptome from bulk RNA of infection-naïve versus imprinted patients with SARS-CoV-2 Omicron B.1.1.529
title_full Decoding the transcriptome from bulk RNA of infection-naïve versus imprinted patients with SARS-CoV-2 Omicron B.1.1.529
title_fullStr Decoding the transcriptome from bulk RNA of infection-naïve versus imprinted patients with SARS-CoV-2 Omicron B.1.1.529
title_full_unstemmed Decoding the transcriptome from bulk RNA of infection-naïve versus imprinted patients with SARS-CoV-2 Omicron B.1.1.529
title_short Decoding the transcriptome from bulk RNA of infection-naïve versus imprinted patients with SARS-CoV-2 Omicron B.1.1.529
title_sort decoding the transcriptome from bulk rna of infection naive versus imprinted patients with sars cov 2 omicron b 1 1 529
topic transcriptome analysis
total RNA-seq
imprinted immune response
infection-naïve immune response
SARS-CoV-2 Omicron B.1.1.529
gene expression
url https://journals.asm.org/doi/10.1128/spectrum.02914-24
work_keys_str_mv AT sissytheresesonnleitner decodingthetranscriptomefrombulkrnaofinfectionnaiveversusimprintedpatientswithsarscov2omicronb11529
AT samirawalder decodingthetranscriptomefrombulkrnaofinfectionnaiveversusimprintedpatientswithsarscov2omicronb11529
AT evahinterbichler decodingthetranscriptomefrombulkrnaofinfectionnaiveversusimprintedpatientswithsarscov2omicronb11529
AT ludwigknabl decodingthetranscriptomefrombulkrnaofinfectionnaiveversusimprintedpatientswithsarscov2omicronb11529
AT roswithapoernbacher decodingthetranscriptomefrombulkrnaofinfectionnaiveversusimprintedpatientswithsarscov2omicronb11529
AT gernotwalder decodingthetranscriptomefrombulkrnaofinfectionnaiveversusimprintedpatientswithsarscov2omicronb11529